Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
BeOne Medicines
BeOne Medicines
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Gilead Sciences
Seagen Inc.
Genmab
Merck Sharp & Dohme LLC
AstraZeneca
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Mirati Therapeutics Inc.
Eli Lilly and Company
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Incyte Corporation
Revolution Medicines, Inc.
Qilu Pharmaceutical Co., Ltd.
Hoffmann-La Roche
Bristol-Myers Squibb
AstraZeneca
AstraZeneca
AbbVie
Pfizer
Bristol-Myers Squibb
AstraZeneca
Regeneron Pharmaceuticals
AbbVie
Hoffmann-La Roche
Daiichi Sankyo
Allist Pharmaceuticals, Inc.
AstraZeneca
Gilead Sciences
BeOne Medicines
Revolution Medicines, Inc.
Merck Sharp & Dohme LLC
Hoffmann-La Roche
GlaxoSmithKline
Taiho Oncology, Inc.
Gilead Sciences
AstraZeneca
Eikon Therapeutics
Regeneron Pharmaceuticals
Genprex, Inc.
Hoffmann-La Roche
Bristol-Myers Squibb
Bristol-Myers Squibb
AstraZeneca